Sotatercept in Patients With MPN-Associated Myelofibrosis and Anemia

December 16, 2017
Srdan Verstovsek, MD

Srdan Verstovsek, MD, of MD Anderson Cancer Center, discusses a study of sotatercept (ACE-011) alone and in combination with ruxolitinib in patients with myeloproliferative neoplasm (MPN)-associated myelofibrosis and anemia.